Smallecule
JAK inhibitors: New Delays by FDA
During the past couple of weeks, three large companies, AbbVie, Lilly, and Pfizer have recieved requests by the FDA that...
Read More
FDA Approves Viloxazine: A New ADHD Treatment For Children
60 million children in the U.S. have been diagnosed with ADHD, accounting to almost 10% of all children (1). Many...
Read MoreJAK Inhibitor Upadacitinib Repurpoused as a Potential Psoriatic Arthritis Treatment
AbbVie has recently come out with updates on applications of Rinvoq, generic name upadacitinib, which has already been approved as...
Read MoreThe Better Future of Chemotherapy: Myeloprotection Therapy for Small-Cell Lung Cancer
Bone marrow suppression is a virtually ubiquitous side effect of chemotherapy that limits the dose of the chemo drug. However,...
Read MoreNew NSAID That Is Easier on the Stomach: Antibe Theraputics IND Application Approved by FDA
The Non Steroidal Anti Inflammatory Drug (NSAID) class is present in virtually every household and first aid kit. However, widely-popular...
Read More
About Me
Dapibus id interdum fusce sed odio massa tellus amet, faucibus nibh consequat justo mauris, donec nec tempus in volutpat iaculis pellentesque in urna.
Dapibus id interdum fusce sed odio massa tellus amet, faucibus nibh consequat justo mauris, donec nec tempus in volutpat iaculis pellentesque in urna.
Dapibus id interdum fusce sed odio massa tellus amet, faucibus nibh consequat justo mauris, donec nec tempus in volutpat iaculis pellentesque in urna.
Dapibus id interdum fusce sed odio massa tellus amet, faucibus nibh consequat justo mauris, donec nec tempus in volutpat iaculis pellentesque in urna.